Competition no obstacle in a new cancer project created by consortium.
Cancer hospitals always are quick to explain that they are different, often pointing to their special commitment to their patients and ability to deal with end-of-life issues. But those differences are rarely accounted for in the benchmarking data they use. The facilities have a keen sense of competition and have, until recently, been unwilling to come together for benchmarking purposes. But all that changed in 1997 when the Joint Commission on Accreditation of Healthcare Organizations started talking about ORYX. Cancer hospital executives knew from experience that comparing data with noncancer hospitals wouldn't be useful, so a group of them came together and created a National Cancer Database initiative that would allow for subcomparisons within the ORYX system.
D019985:Benchmarking; D016063:Blood Loss, Surgical; D002173:Cancer Care Facilities / Q000458:organization & administration / Q000592:standards*; D016208:Databases, Factual; D004066:Digestive System Diseases; D006801:Humans; D009196:Myeloproliferative Disorders / Q000150:complications / Q000401:mortality; D009369:Neoplasms / Q000150:complications* / Q000401:mortality; D019984:Quality Indicators, Health Care; D012120:Respiration Disorders; D012871:Skin Diseases; D017749:Total Quality Management / Q000458:organization & administration; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology